This study reports an important and novel finding that TENT5A, an enzyme involved in fine-tuning poly(A) tail length on selected mRNAs, is required for proper enamel mineralization in mice. The ...

The partnership combines RRG’s FDA-registered, CLIA-certified laboratory and industry-leading biologic products with ...

Researchers used advanced imaging to uncover early molecular changes in bone that may enable earlier diagnosis of ...

Grand Pharmaceutical Group Limited announced that its experimental drug STC3141 met the primary clinical endpoint in a Phase ...

Researchers suggest targeting ECM-mediated regulation of autophagy levels could be used to sensitize pancreatic cancer to FDA-approved therapies.

Product-focused roadmap shows how MSC secretomes can become scalable, standardized, GMP-ready biotherapeutics.

After an FDA rejection of its spinocerebellar ataxia (SCA) therapy, Biohaven was forced to rethink its strategy—cutting R&D spend by 60% and channeling the spirit of a scrappy startup again as it ...

PET-based imaging study designed to assess the biodistribution of CIT-013 and associate disease activity with CIT-013 target disposition in participants with rheumatoid arthritis and hidradenitis ...

A feature of pancreatic cancer cells' surroundings determines whether they grow fast or become resistant to chemotherapy, a ...

A feature of pancreatic cancer cells' surroundings determines whether they grow fast or become resistant to chemotherapy, a new study shows.

Other income, primarily interest on cash balances, declined to $44,000 for the quarter from $60,000 in the same period last year. The drop in interest income, though modest in absolute terms, further ...